Olodaterol

Generic Name
Olodaterol
Brand Names
Inspiolto Respimat, Stiolto, Striverdi Respimat
Drug Type
Small Molecule
Chemical Formula
C21H26N2O5
CAS Number
868049-49-4
Unique Ingredient Identifier
VD2YSN1AFD
Background

Olodaterol is a novel, long-acting beta2-adrenergic agonist (LABA) that exerts its pharmacological effect by binding and activating beta2-adrenergic receptors located primarily in the lungs. Beta2-adrenergic receptors are membrane-bound receptors that are normally activated by endogenous epinephrine whose signalling, via a downstream L-type calcium channel i...

Indication

Olodaterol is indicated for use in chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is not indicated for the treatment of acute exacerbations of COPD or for the treatment of asthma.

Associated Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Associated Therapies
-

Olodaterol Bridging Study in Asthma

First Posted Date
2011-09-05
Last Posted Date
2011-11-22
Lead Sponsor
Boehringer Ingelheim
Registration Number
NCT01428622
Locations
🇫🇷

1249.7.33003 Boehringer Ingelheim Investigational Site, Gières, France

© Copyright 2024. All Rights Reserved by MedPath